Skip to main content

Mouse Behavioural Studies and What They Can Teach Us about Prion Diseases

  • Chapter
Neurodegeneration and Prion Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. E. Bruce, R. G. Will, J. W. Ironside, I. McConnell, D. Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser and C. J. Bostock, Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389, 498–501. (1997).

    Article  PubMed  Google Scholar 

  2. M. D. Spencer, R. S. Knight, and R. G. Will, First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. Bmj 324, 1479–1482. (2002).

    Article  PubMed  Google Scholar 

  3. I. Zerr and S. Poser, Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. Apmis 110, 88–98. (2002).

    Article  PubMed  Google Scholar 

  4. A. Otto, I. Zerr, M. Lantsch, K. Weidehaas, C. Riedemann and S. Poser, Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 64, 524–528. (1998).

    PubMed  Google Scholar 

  5. M. E. Bruce, I. McConnell, H. Fraser and A. G. Dickinson, The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72, 595–603. (1991).

    PubMed  Google Scholar 

  6. M. Jeffrey, W. G. Halliday, J. Bell, A. R. Johnston, N. K. MacLeod, C. Ingham, A. R. Sayers, D. A. Brown and J. R. Fraser, Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 26, 41–54. (2000).

    PubMed  Google Scholar 

  7. S. Betmouni, R. M. J. Deacon, J. N. P. Rawlins and V. H. Perry, Behavioural consequences of prion disease targeted to the hippocampus in a mouse model of scrapie. Psychobiology 27(1), 63–71 (1999).

    Google Scholar 

  8. R. M. Deacon, J. M. Raley, V. H. Perry and J. N. Rawlins, Burrowing into prion disease. Neuroreport 12, 2053–2057. (2001).

    PubMed  Google Scholar 

  9. K. Guenther, R. M. Deacon, V. H. Perry and J. N. Rawlins, Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14, 401–409. (2001).

    PubMed  Google Scholar 

  10. C. Cunningham, R. Deacon, H. Wells, D. Boche, S. Waters, C. P. Diniz, H. Scott, J. N. Rawlins and V. H. Perry, Synaptic changes characterize early behavioural changes inthe ME7 modelof murine prion disease. Eur. J. Neurosci. 17, 2147–2155 (2003).

    Article  PubMed  Google Scholar 

  11. C. J. Gordon, P. Becker and J. S. AIi, Behavioral thermoregulatory responses of single-and group-housed mice. Physiol Behav 65, 255–262. (1998).

    PubMed  Google Scholar 

  12. J. P. Konsman, P. Parnet, and R. Dantzer, Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25, 154–159. (2002).

    PubMed  Google Scholar 

  13. A. Aubert, G. Goodall, R. Dantzer and G. Gheusi, Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice. Brain Behav Immun 11, 107–118. (1997).

    PubMed  Google Scholar 

  14. G. W. Outram, Changes in drinking and feeding habits of mice with experimental scrapie. J Comp Pathol 82, 415–427. (1972).

    PubMed  Google Scholar 

  15. A. J. Suckling, S. Bateman, C. B. Waldron, H. E. Webb and R. H. Kimberlin, Motor activity changes in scrapie-affected mice. Br J Exp Pathol 57, 742–746 (1976).

    PubMed  Google Scholar 

  16. G. DeH’Omo, E. Vannoni, A. L. Vyssotski, M. A. Di Bari, R. Nonno, U. Agrimi and H. P. Lipp, Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur J Neurosci 16, 735–742. (2002).

    PubMed  Google Scholar 

  17. R. Yirmiya, Endotoxin produces a depressive-like episode in rats. Brain Res 711, 163–174. (1996).

    PubMed  Google Scholar 

  18. T. Borowski, L. Kokkinidis, Z. Merali, and H. Anisman, Lipopolysaccharide, central in vivo biogenicamine variations, and anhedonia. Neuroreport 9, 3797–3802. (1998).

    PubMed  Google Scholar 

  19. G. W. Outram, H. Fraser and D. T. Wilson, Scrapie in mice. Some effects on the brain lesion profile of ME7 agent due to genotype of donor, route of injection and genotype of recipient. J Comp Pathol 83, 19–28. (1973).

    PubMed  Google Scholar 

  20. R. I. Carp, Y. S. Kim, and S. M. Callahan, Scrapie-induced alterations in glucose tolerance in mice. J Gen Virol 70, 827–835. (1989).

    PubMed  Google Scholar 

  21. G. W. Kreutzberg, Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19, 312–318. (1996).

    PubMed  Google Scholar 

  22. A. W. Hetherington, and S. W. Ranson,. The spontaneous activity and food intake of rats with hypothalamic lesions. Am J Physiol 136, 609–617 (1942).

    Google Scholar 

  23. R. M. Deacon, A. Croucher and J. N. Rawlins, Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res 132, 203–213. (2002).

    PubMed  Google Scholar 

  24. R. C. Bolles and M. S. Fanselow, A perceptual-defensive recuperative model of fear and pain. Behav Brain Sci 3, 291–323 (1980).

    Google Scholar 

  25. D. T. Walsh, S. Betmouni and V. H. Perry, Absenceof detectable IL-1beta production in murine prion disease: a model of chronic neurodegeneration. J Neuropathol Exp Neurol 60, 173–182. (2001).

    PubMed  Google Scholar 

  26. C. Cunningham, D. Boche and V. H. Perry, Transforming growth factor betai, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix. Neuropathol Appl Neurobiol 28, 107–119. (2002).

    PubMed  Google Scholar 

  27. T. Cartmell, G. N. Luheshi and N. J. Rothwell, Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J Physiol 518, 585–594. (1999).

    PubMed  Google Scholar 

  28. R. M. J. Deacon, and J. N. P Rawlins, Hippocampal lesions, species-typical behaviours and anxiety in mice. Behav Brain Res 156, 241–249 (2005).

    PubMed  Google Scholar 

  29. B. Reisberg, S. Finkel, J. Overall, N. Schmidt-Gollas, S. Kanowski, H. Lehfeld, F. Hulla, S. G. Sclan, H. U. Wilms, K. Heininger, I. Hindmarch, M. Stemmler, L. Poon, A. Kluger, C. Cooler, M. Bergener, L. Hugonot-Diener, P. H. Robert, S. Antipolis and H. Erzigkeit, The Alzheimer’s disease activities of daily living international scale (ADL-IS). Int Psychogeriatr, 13 163–181. (2001).

    PubMed  Google Scholar 

  30. R. Nitrini, L. S. Teixeira da Silva, S. Rosemberg, P. Caramelli, P. E. Carrilho, P. lughetti, M. R. Passos-Bueno, M. Zatz, S. Albrecht and A. LeBlanc, Prion disease resembling frontotemporal dementia and parkinsonism linked to chromosome 17. Arq Neuropsiquiatr 59, 161–164. (2001).

    PubMed  Google Scholar 

  31. S. E. Glickman and B. J. Morrison, Some behavioural and neural correlates of predation susceptibility in mice. Commun Behav Biol A 4, 261–267 (1969).

    Google Scholar 

  32. C. Masullo and G. Macchi, Resistance of the hippocampus in Creutzfeldt-Jakob disease. Clin Neuropathol 16, 37–14. (1997).

    PubMed  Google Scholar 

  33. H. Mizusawa, A. Hirano and J. F. Llena, Involvement of hippocampus in Creutzfeldt-Jakob disease. J Neurol Sci 82, 13–26. (1987).

    PubMed  Google Scholar 

  34. M. A. Poon, S. Stuckey and E. Storey, MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease. Neuroradiology 43, 746–749. (2001).

    PubMed  Google Scholar 

  35. D. McFarland and J. Hotchin, Early behavioral abnormalities in mice due to scrapie virus encephalopathy. Biol Psychiatry 15, 37–44 (1980).

    PubMed  Google Scholar 

  36. I. Tobler, T. Deboer and M. Fischer, Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 17, 1869–1879. (1997).

    PubMed  Google Scholar 

  37. E. Choleris, A. W. Thomas, M. Kavaliers and F. S. Prato, A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25, 235–260. (2001).

    PubMed  Google Scholar 

  38. A. J. Hunter, M. P. Caulfield and R. H. Kimberlin, Learning ability of mice infected with differentstrains of scrapie. Physiol Behav 36, 1089–1092. (1986).

    PubMed  Google Scholar 

  39. S. R. Bareggi, D. Braida, M. Gervasoni, G. Carcassola, C. Pollera, C. Verzoni, M. Sala and C. Vergerio, Neurochemical and behavioural modifications induced by scrapie infection in golden hamsters. Brain Res 984, 237–241. (2003).

    PubMed  Google Scholar 

  40. A. M. Lysons and S. J. Woollard, Spatial reversal learning in preclinical scrapie-inoculated mice. Neuroreport, 7 1087–1091 (1996).

    PubMed  Google Scholar 

  41. M. Zeidler, R. J. Sellar, D. A. Collie, R. Knight, G. Stewart, M. A. Macleod, J. W. Ironside, S. Cousens, A. C. Colchester, D. M. Hadley, R. G. Will and A. F. Colchester, The pulvinarsign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355, 1412–1418. (2000).

    PubMed  Google Scholar 

  42. D. Brown, P. Belichenko, J. Sales, M. Jeffrey and J. R. Fraser, Early loss of dendritic spines in murine scrapie revealed by confocal analysis. Neuroreport 12, 179–183. (2001).

    PubMed  Google Scholar 

  43. P. V. Belichenko, D. Brown, M. Jeffrey and J. R. Fraser, Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice. Neuropathol Appl Neurobiol 26, 143–149. (2000).

    PubMed  Google Scholar 

  44. M. Jeffrey, C. M. Goodsir, M. E. Bruce, P. A. McBride and J. R. Fraser, In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol Appl Neurobiol 23, 93–101. (1997).

    PubMed  Google Scholar 

  45. H. Fraser and A. G. Dickinson, Distribution of experimentally induced scrapie lesions inthebrain. Nature 216, 1310–1311 (1967).

    PubMed  Google Scholar 

  46. R. M. Ridley and H. F. Baker, To what extent is strain variation evidence for an independent genome in the agent of the transmissible spongiform encephalopathies? Neurodegeneration 5, 219–231. (1996).

    PubMed  Google Scholar 

  47. C. Cunningham, R. Deacon, K. Chan, D. Boche, J. N. P. Rawlins and V. H. Perry, Neuropathologically distinct strains give rise to similar temporal profiles of behavioural impairments. Neurobiol. Dis. 18, 258–269 (2005).

    PubMed  Google Scholar 

  48. J. I. Kim, W. K. Ju, J. H. Choi, E. Choi, R. I. Carp, H. M. Wisniewski and Y. S. Kim, Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Brain Res Mol Brain Res 73, 17–27. (1999).

    PubMed  Google Scholar 

  49. M. A. Macleod, G. E. Stewart, M. Zeidler, R. Will and R. Knight, Sensory features of variant Creutzfeldt-Jakob disease. J Neurol 249, 706–711. (2002).

    PubMed  Google Scholar 

  50. J. D. Schmahmann, Vascular syndromes of the thalamus. Stroke 34, 2264–2278. Epub 2003 Aug 2221. (2003).

    PubMed  Google Scholar 

  51. H. Urbach, J. Klisch, H. K. Wolf, D. Brechtelsbauer, S. Gass and L. Solymosi, MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 40, 65–70. (1998).

    PubMed  Google Scholar 

  52. B. Canciani, M. G. Bruzzone and T. Awan, Neuropathological correlatesof magnetic resonance abnormalities in experimental prion disease. J Neuropathol Exp Neurol 58, 560 (1999).

    Google Scholar 

  53. H. J. Tschampa, J. W. Herms, W. J. Schulz-Schaeffer, B. Maruschak, O. Windl, U. Jastrow, I. Zerr, B. J. Steinhoff, S. Poser and H. A. Kretzschmar, Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology. Brain 125, 2558–2566. (2002).

    PubMed  Google Scholar 

  54. H. J. Tschampa, P. Murtz, S. Flacke, S. Paus, H. H. Schild and H. Urbach, Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 24, 908–915. (2003).

    PubMed  Google Scholar 

  55. E. Lugaresi, I. Tobler, P. Gambetti and P. Montagna, The pathophysiology of fatal familial insomnia. Brain Pathol 8, 521–526. (1998).

    PubMed  Google Scholar 

  56. G. Macchi, G. Rossi, A. L. Abbamondi, G. Giaccone, D. Mancia, F. Tagliavini and O. Bugiani, Diffuse thalamic degeneration in fatal familial insomnia. A morphometric study. Brain Res 771, 154–158. (1997).

    PubMed  Google Scholar 

  57. M. A. Klein, P. S. Kaeser, P. Schwarz, H. Weyd, I. Xenarios, R. M. Zinkernagel, M. C. Carroll, J. S. Verbeek, M. Botto, M. J. Walport, H. Molina, U. Kalinke, H. Acha-Orbea and A. Aguzzi, Complement facilitates early prion pathogenesis. Nat Med 7, 488–192. (2001).

    PubMed  Google Scholar 

  58. M. Burwinkel, A. Schwarz, C. Riemer, J. Schultz, F. Van Landeghem and M. Baier, Rapid disease development in scrapie-infected mice deficient for CD40 ligand. EMBO Rep 8, 8 (2004).

    Google Scholar 

  59. L. Manuelidis, W. Fritch and I. Zaitsev, Dapsone to delay symptoms in Creutzfeldt-Jakob disease. Lancet 352, 456. (1998).

    PubMed  Google Scholar 

  60. S. Supattapone, H. O. Nguyen, F. E. Cohen, S. B. Prusiner and M. R. Scott, Elimination of prions by branched polyamines and implications fortherapeutics. Proc Natl Acad Sci USA 96, 14529–14534. (1999).

    PubMed  Google Scholar 

  61. A. R. White, P. Enever, M. Tayebi, R. Mushens, J. Linehan, S. Brandner, S. Anstee, J. Collinge and S. Hawke, Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80–83. (2003).

    PubMed  Google Scholar 

  62. V. Perrier, J. Solassol, C. Crozet, Y. Frobert, C. Mourton-Gilles, J. Grassi and S. Lehmann, Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J Neurochem 89, 454–163. (2004).

    PubMed  Google Scholar 

  63. S. A. Priola, A. Raines and W. S. Caughey, Porphyrin and phthalocyanine antiscrapie compounds. Science 287, 1503–1506. (2000).

    PubMed  Google Scholar 

  64. M. W. Head, C. F. Farquhar, N. A. Mabbott and J. R. Fraser, The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic intervention. Expert Opin Ther Targets 5, 569–585. (2001).

    PubMed  Google Scholar 

  65. G. Mallucci, A. Dickinson, J. Linehan, P. C. Klohn, S. Brandner and J. Collinge, Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871–874. (2003).

    Article  PubMed  Google Scholar 

  66. R. H. Kimberlin, S. Cole and C. A. Walker, Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microb Pathog 2, 405–415. (1987).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Cunningham, C. (2005). Mouse Behavioural Studies and What They Can Teach Us about Prion Diseases. In: Brown, D.R. (eds) Neurodegeneration and Prion Disease. Springer, Boston, MA. https://doi.org/10.1007/0-387-23923-5_5

Download citation

Publish with us

Policies and ethics